| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |